Name | Tofacitinib |
---|---|
Supplier | Cell Signaling Technology |
Catalog | 14703 |
Prices | $99.00 |
Sizes | 10 mg |
Formula | C16H20N6O |
Molecular Weight | 312.37 g/mol |
Purity | >99% |
Description | Tofacitinib is a cell permeable Janus kinase (JAK) inhibitor with demonstrated preference to inhibiting JAK1 and JAK3 (1). Tofacitinib inhibits JAK isoforms 1, 2, and 3 with IC 50 values of 6.1, 12, and 8.0 nM, respectively; the reported IC 50 value relative to Tyk2 is 176 nM (2). Research studies show that tofacitinib primarily blocks γ c cytokine receptors and inhibits cytokine production, which suggests that tofacitinib blocks cytokine action during both innate and adaptive responses (1,3). The overall effect of tofacitinib is to reduce inflammatory responses through selective inhibition of JAK family members (4). |
Supplier Page | Shop |